Literature DB >> 26536357

Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.

Rok Kogoj1, Tatjana Mrvic, Marina Praprotnik, Darja Kese.   

Abstract

In this retrospective study we employed real-time polymerase chain reaction (PCR) to analyse the occurrence of Mycoplasma pneumoniae among upper and lower respiratory tract infections (RTI) in the Central Region of Slovenia between January 2006 and December 2014. We also used a culture and pyrosequencing approach to genotype strains and infer their potential macrolide resistance. Of a total 9,431 tested samples from in- and out-patient with RTI, 1,255 (13%) were found to be positive by M. pneumoniae PCR. The proportion of positive samples was 19% (947/5,092)among children (≤16 years-old) and 7% (308/4,339) among adults (>16 years-old). Overall, among those PCR tested, the highest proportions of M. pneumonia infections during the study period were observed in 2010 and 2014. In these two years, 18% (218/1,237) and 25% (721/2,844) of samples were positive respectively,indicating epidemic periods. From the 1,255 M. pneumoniae PCR-positive samples, 783 (614 from paediatric and 169 from adult patients) were successfully cultured. Of these, 40% (312/783) were constituted of strains belonging to the P1 type II genomic group, while 60% (469/783) contained strains of the P1 type I group. Two isolates comprised both P1 type Iand II strains. Results of a genotype analysis by year,showed that the dominant M. pneumoniae P1 type during the 2010 epidemic was P1 type II (82% of isolates;81/99), which was replaced by P1 type I in the 2014 epidemic (75%; 384/510). This observation could indicate that the two epidemics may have been driven by a type shift phenomenon, although both types remained present in the studied population during the assessed period of time. Only 1% of strains (7/783) were found to harbour an A2063G mutation in the 23S rRNA gene,which confers macrolide resistance, suggesting that the occurrence of M. pneumoniae macrolide resistance still seems to be sporadic in our geographic area.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26536357     DOI: 10.2807/1560-7917.ES.2015.20.37.30018

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  20 in total

1.  Mycoplasma pneumoniae in Community-Acquired Lower Respiratory Tract Infections.

Authors:  Surinder Kumar; Indu Bala Garg; Gulshan Rai Sethi
Journal:  Indian J Pediatr       Date:  2018-01-10       Impact factor: 1.967

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.

Authors:  R Kogoj; M Praprotnik; T Mrvič; M Korva; D Keše
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-09-26       Impact factor: 3.267

Review 4.  Molecular Tools for Typing Mycoplasma pneumoniae and Mycoplasma genitalium.

Authors:  Roger Dumke
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

5.  Clinical characteristics of infections caused by Mycoplasma pneumoniae P1 genotypes in children.

Authors:  Jasna Rodman Berlot; Uroš Krivec; Marina Praprotnik; Tatjana Mrvič; Rok Kogoj; Darja Keše
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-30       Impact factor: 3.267

6.  Mycoplasma pneumoniae P1 Genotype Indicates Severity of Lower Respiratory Tract Infections in Children.

Authors:  Jasna Rodman Berlot; Uroš Krivec; Tatjana Mrvič; Rok Kogoj; Darja Keše
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

7.  Clinical Evaluation of a Novel Point-of-Care Assay To Detect Mycoplasma pneumoniae and Associated Macrolide-Resistant Mutations.

Authors:  Toshihiko Kakiuchi; Ippei Miyata; Reiji Kimura; Goh Shimomura; Kunihisa Shimomura; Satoru Yamaguchi; Takato Yokoyama; Kazunobu Ouchi; Muneaki Matsuo
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

8.  Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting.

Authors:  Yacui Wang; Baoping Xu; Xirong Wu; Qingqin Yin; Yi Wang; Jieqiong Li; Weiwei Jiao; Shuting Quan; Lin Sun; Yonghong Wang; Adong Shen
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

Review 9.  Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae.

Authors:  Tsutomu Yamazaki; Tsuyoshi Kenri
Journal:  Front Microbiol       Date:  2016-05-23       Impact factor: 5.640

Review 10.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.